1. |
Chang LK, Fine HF, Spaide RF, et al. Ultrastructural correlation of spectral-domain optical coherence tomographic findings in vitreomacular traction syndrome[J]. Am J Ophthalmol, 2008, 146(1): 121-127. DOI: 10.1016/j.ajo.2008.03.001.
|
2. |
Johnson MW. Posterior vitreous detachment: evolution and complications of its early stages[J]. Am J Ophthalmol, 2010, 149(3): 371-382. DOI: 10.1016/j.ajo.2009.11.022.
|
3. |
Sebag J. Anomalous posterior vitreous detachment: a unifying concept in vitreo-retinal disease[J]. Graefe’s Arch Clin Exp Ophthalmol, 2004, 242(8): 690-698. DOI: 10.1007/s00417-004-0980-1.
|
4. |
Steel DH, Lotery AJ. Idiopathic vitreomacular traction and macular hole: a comprehensive review of pathophysiology, diagnosis, and treatment[J]. Eye(Lond), 2013, 27 Suppl 1: S1-21. DOI: 10.1038/eye.2013.212.
|
5. |
Johnson MW. How should we release vitreomacular traction: surgically, pharmacologically, or pneumatically?[J]. Am J Ophthalmol, 2013, 155(2): 203-205. DOI: 10.1016/j.ajo.2012.10.016.
|
6. |
Hikichi T, Yoshida A, Trempe CL. Course of vitreomacular traction syndrome[J]. Am J Ophthalmol, 1995, 119(1): 55-61. DOI: 10.1016/s0002-9394(14)73813-9.
|
7. |
Errera MH, Liyanage SE, Petrou P, et al. A Study of the natural history of vitreomacular traction syndrome by OCT[J]. Ophthalmology, 2018, 125(5): 701-707. DOI: 10.1016/j.ophtha.2017.10.035.
|
8. |
Sayegh RG, Georgopoulos M, Geitzenauer W, et al. High-resolution optical coherence tomography after surgery for vitreomacular traction: a 2-year follow-up[J]. Ophthalmology, 2010, 117(10): 2010-2017. DOI: 10.1016/j.ophtha.2010.01.041.
|
9. |
Rodrigues IA, Stangos AN, McHugh DA, et al. Intravitreal Injection of expansile perfluoropropane (C3F8) for the treatment of vitreomacular traction[J]. Am J Ophthalmol, 2013, 155(2): 270-276. DOI: 10.1016/j.ajo.2012.08.018.
|
10. |
Chan CK, Crosson JN, Mein CE, et al. Pneumatic vitreolysis for relief of vitreomacular traction[J]. Retina, 2017, 37(10): 1820-1831. DOI: 10.1097/iae.0000000000001448.
|
11. |
Steinle NC, Dhoot DS, Ruiz CQ, et al. Treatment of vitreomacular traction with intravitreal perfluoropropane (C3F8) injection[J]. Retina, 2017, 37(4): 643-650. DOI: 10.1097/iae.0000000000001237.
|
12. |
Duker J, Kaiser PK, Binder S, et al. The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole[J]. Ophthalmology, 2013, 120(12): 2611-2619. DOI: 10.1016/j.ophtha.2013.07.042.
|
13. |
曾苗, 陈晓, 洪玲, 等. 特发性黄斑前膜患眼玻璃体切割联合内界膜剥除手术前后视力视物变形度与黄斑形态结构的相关性[J]. 中华眼底病杂志, 2017, 33(4): 378-382. DOI: 10.3760/cma.j.issn.1005-1015.2017.04.Zeng M, Chen X, Hong L, et al. Correlation of visual acuity and metamorphopsia with foveal morphology before and after vitrectomy with internal limiting membrane peeling in idiopathic macular epiretinal membrane eyes[J]. Chin J Ocul Fundus Dis, 2017, 33(4): 378-382. DOI: 10.3760/cma.j.issn.1005-1015.2017.04.
|
14. |
Singh RP, Li A, Bedi R, et al. Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome[J]. Br J Ophthalmol, 2014, 98(4): 356-360. DOI: 10.1136/bjophthalmol-2013-304219.
|
15. |
Chan CK, Wessels IF, Friedrichsen EJ. Treatment of idiopathic macular holes by induced posterior vitreous detachment[J]. Ophthalmology, 1995, 102(5): 757-767. DOI: 10.1016/s0161-6420(95)30958-x.
|
16. |
Mori K, Saito S, Gehlbach PL, et al. Treatment of stage 2 macular hole by intravitreous injection of expansile gas and induction of posterior vitreous detachment[J]. Ophthalmology, 2007, 114(1): 127-133. DOI: 10.1016/j.ophtha.2006.07.001.
|
17. |
Day S, Martinez JA, Nixon PA, et al. Intravitreal sulfur hexafluoride injection for the treatment of vitreomacular traction syndrome[J]. Retina, 2016, 36(4): 733-737. DOI: 10.1097/iae.0000000000000760.
|
18. |
McHugh D, Gupta B, Saeed M. Intravitreal gas injection for the treatment of diabetic macular edema[J]. Clin Ophthalmol, 2011, 5(10): 1543-1548. DOI: 10.2147/opth.s25348.
|
19. |
Dugel PU, Tolentino M, Feiner L, et al. Results of the 2-year ocriplasmin for treatment for symptomatic vitreomacular adhesion including macular hole (OASIS) randomized trial[J]. Ophthalmology, 2016, 123(10): 2232-2247. DOI: 10.1016/j.ophtha.2016.06.043.
|
20. |
Park KA, Kim J, Oh SY. Analysis of spectral domain optical coherence tomography measurements in optic neuritis: differences in neuromyelitis optica, multiple sclerosis, isolated optic neuritis and normal healthy controls[J]. Acta Ophthalmol, 2014, 92(1): 57-65. DOI: 10.1111/aos.12215.
|
21. |
Roberto DO, Mura M. Metamorphopsia and optical coherence tomography findings after rhegmatogenous retinal detachment surgery[J]. Am J Ophthalmol, 2014, 157(6): 1322-1323. DOI: 10.1016/j.ajo.2014.02.024.
|
22. |
Okamoto F, Sugiura Y, Okamoto Y, et al. Inner nuclear layer thickness as a prognostic factor for metamorphopsia after epiretinal membrane surgery[J]. Retina, 2015, 35(10): 2107-2114. DOI: 10.1097/IAE.0000000000000602.
|
23. |
Jackson TL, Nicod E, Angelis A, et al. Pars plana vitrectomy for vitreomacular traction syndrome: a systematic review and metaanalysis of safety and efficacy[J]. Retina, 2013, 33(10): 2012-2017. DOI: 10.1097/IAE.0b013e3182a6b3e2.
|
24. |
Feng H, Adelman R. Cataract formation following vitreoretinal procedures[J]. Clin Ophthalmol, 2014, 8(9): 1957-1965. DOI: 10.2147/OPTH.S68661.
|